Skip to main content
NanoRepro AG logo

NanoRepro AG — Investor Relations & Filings

Ticker · NN6 ISIN · DE0006577109 LEI · 3912008FCA63AGIMEV74 F Manufacturing
Open in API
Filings indexed 415 across all filing types
Latest filing 2011-07-07 Environmental & Social …
Country DE Germany
Listing F NN6

About NanoRepro AG

https://www.nanorepro.com/en/

NanoRepro AG is a company specializing in the development, manufacturing, and distribution of CE-marked rapid diagnostic tests (self-tests) and food supplements. The products are designed for both home and professional use. The company's portfolio covers various health areas, including family planning, preventive healthcare, disease detection, food intolerances, allergies, and infectious diseases. The primary goal is to provide accuracy in self-diagnostics for rapid disease detection and health monitoring.

Recent filings

Filing Released Lang Actions
NanoRepro AG: Das Marburger Unternehmen launcht Internetseite www.zuhausetest.de
Environmental & Social Information Classification · 99% confidence The document is a press release dated July 7, 2011, announcing that NanoRepro AG launched a new website (www.zuhausetest.de) to boost direct sales of their medical self-tests. It discusses strategic decisions, marketing activities, recent sales performance, and future product launches (Prostata-Gesundheitstest ProstaQUICK). This type of announcement, focusing on strategic business updates, marketing initiatives, and general corporate news that doesn't fit a specific financial report (like 10-K, ER, or IR), is best classified as a general Regulatory Filing or Corporate News announcement. Since it is not a formal financial report, a management discussion, or a specific regulatory disclosure like insider trading or dividend notice, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate news releases distributed via services like DGAP.
2011-07-07 German
NanoRepro AG: Bakterium greift den Magen an - Marburger Unternehmen fuhrt Magen-Gesundheitstest Heli-C-CHECK ein
Regulatory Filings Classification · 100% confidence The document is explicitly labeled as a "Press Release" dated June 29, 2011, announcing a new product (Heli-C-CHECK) from NanoRepro AG related to health diagnostics. It details the product's function, the medical condition it addresses (Helicobacter pylori infection), and its availability. This format—a news announcement about a company development, product launch, or general update, rather than a formal regulatory filing (like 10-K, IR, or ER) or a transcript—best fits the general category for non-standard regulatory announcements or press releases. Since there is no specific category for a 'Product Launch Press Release,' and it is not a formal financial report, the most appropriate fallback category is 'Regulatory Filings' (RNS), which often serves as a catch-all for general corporate news releases distributed via news services (like DGAP mentioned at the end). The document length (4323 chars) is short, but it is the primary content, not an announcement *of* another report.
2011-06-29 German
NanoRepro AG: Marburger Unternehmen schliet ersten Kaufvertrag fur den russischen Markt
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated June 29, 2011, announcing two major corporate events: 1) A significant exclusive distribution contract for the Russian market with defined purchase volumes, and 2) The successful placement of a capital increase (equity financing) resulting in a gross proceeds of 0.93 million Euro. The structure, use of keywords like 'Schlagwort(e): Vertrag/Kapitalerhöhung', and the concluding section mentioning 'Corporate News/Finanznachricht, übermittelt durch die DGAP' strongly indicate this is a regulatory news announcement concerning financing and material contracts. Since it details a successful capital increase and a major sales contract, it directly relates to financing activities. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). It is not a full financial report (10-K or IR), nor is it just an earnings release (ER) or a general regulatory filing (RNS), as it focuses specifically on capital structure changes and major commercial agreements.
2011-06-29 German
NanoRepro AG: Unternehmen fuhrt den Magen-Gesundheitstest Heli-C-CHECK ein
Regulatory Filings Classification · 100% confidence The document is a press release dated June 27, 2011, announcing the launch of a new product, the 'Heli-C-CHECK' stomach health test, by NanoRepro AG. It details the product's function, market strategy, and future product pipeline. This type of announcement, focusing on a new product launch and strategic business decision, is best classified as a general corporate news item. Since there is no specific category for 'Product Launch Announcement' and it is not a formal regulatory filing like a 10-K, ER, or IR, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for corporate news releases that don't fit elsewhere, especially when distributed via services like DGAP.
2011-06-27 German
NanoRepro AG: Internationalisierung schreitet voran und Vertragsverhandlungen stehen kurz vor dem Abschluss
Regulatory Filings Classification · 95% confidence The document is a news release dated June 15, 2011, from NanoRepro AG, detailing strategic business updates, international expansion (Austria, Belgium, Luxembourg, Switzerland, Russia, Vietnam), new product launches (ProstaQUICK, Heli-C-CHECK), and ongoing contract negotiations. It is not a formal regulatory filing like a 10-K or an IR, nor is it a transcript (CT) or a specific financial report (ER, IR). It functions as a general corporate update announcing strategic decisions and business progress. Since it is a general corporate news item distributed via DGAP (a common channel for regulatory news/press releases in Germany), and it doesn't fit the specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP), the most appropriate general category is Regulatory Filings (RNS), which serves as the fallback for miscellaneous corporate announcements not covered by more specific codes, especially when distributed through official news channels.
2011-06-15 German
NanoRepro AG: Das Unternehmen legt Grundstein fur Markteintritt in Russland - Partner in Russland gewonnen
Regulatory Filings Classification · 100% confidence The document is a short corporate announcement dated May 12, 2011, detailing a strategic agreement (Vorvertrag) for market entry into Russia with a major pharmacy chain (36,6) and regional agreements. It focuses on business development and strategic decisions rather than detailed financial results (ruling out ER, IR, 10-K) or management changes (MANG). Since it announces a significant business development/contract signing, it fits best under a general strategic announcement category. Given the options, it is not a standard regulatory filing like 10-K or a specific financial report. It is a news release about a strategic partnership/contract. This type of announcement, which is not explicitly covered by other specific codes (like DIV, CAP, TAR), often falls under general Regulatory Filings (RNS) or, if interpreted as a strategic update, could potentially be seen as a general corporate announcement. However, since it is a news release announcing a major contract, and it is short (under 5,000 characters), it strongly resembles a standard regulatory news service release. Given the available codes, RNS (Regulatory Filings - general fallback for miscellaneous announcements) is the most appropriate fit for this type of press release announcing a strategic contract, as it is not a formal financial report or a specific event disclosure like DIRS or DIV.
2011-05-12 German

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.